Compare CHY & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHY | EIKN |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 896.9M | 731.6M |
| IPO Year | N/A | N/A |
| Metric | CHY | EIKN |
|---|---|---|
| Price | $10.80 | $9.94 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.60 |
| AVG Volume (30 Days) | 177.8K | ★ 315.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 10.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.00 | $9.93 |
| 52 Week High | $12.12 | $16.50 |
| Indicator | CHY | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 28.07 | 33.70 |
| Support Level | $10.72 | N/A |
| Resistance Level | $11.08 | $16.34 |
| Average True Range (ATR) | 0.23 | 1.26 |
| MACD | -0.06 | -0.22 |
| Stochastic Oscillator | 2.82 | 1.41 |
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.